Home » Stocks » SWKH

SWK Holdings Corporation (SWKH)

Stock Price: $13.68 USD -0.39 (-2.77%)
Updated Feb 25, 2021 4:00 PM EST - Market closed
Market Cap 182.25M
Revenue (ttm) 35.20M
Net Income (ttm) 9.34M
Shares Out 12.91M
EPS (ttm) 0.72
PE Ratio 18.97
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 25
Last Price $13.68
Previous Close $14.07
Change ($) -0.39
Change (%) -2.77%
Day's Open 14.25
Day's Range 13.68 - 14.74
Day's Volume 8,966
52-Week Range 6.12 - 16.24

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Zacks Investment Research - 1 week ago

SWKH vs. LU: Which Stock Is the Better Value Option?

Other stocks mentioned: LU
PRNewsWire - 1 week ago

DALLAS, Feb. 16, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small and mid-sized commercial-stage companies, tod...

Zacks Investment Research - 3 weeks ago

SWKH vs. RCM: Which Stock Is the Better Value Option?

Other stocks mentioned: RCM
PRNewsWire - 1 month ago

MOUNT OLIVE, N.J., Jan. 4, 2021 /PRNewswire/ -- Flowonix Medical, Inc., a medical device company focused on providing advanced, implantable drug delivery solutions and SWK Holdings Corporation...

PRNewsWire - 2 months ago

DALLAS, Dec. 24, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, to...

PRNewsWire - 3 months ago

DALLAS, Nov. 13, 2020 /PRNewswire/ -- Corporate Highlights Enteris BioPharma, Inc., ("Enteris") a wholly-owned subsidiary of SWK Holdings, recognized $2.5 million in milestone revenue under th...

PRNewsWire - 3 months ago

DALLAS, Nov. 11, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, ...

PRNewsWire - 3 months ago

DALLAS, Oct. 27, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, to...

PRNewsWire - 5 months ago

DALLAS, Sept. 15, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer,...

PRNewsWire - 5 months ago

BOONTON, N.J., Sept. 15, 2020 /PRNewswire/ -- Enteris BioPharma, Inc.

PRNewsWire - 5 months ago

DALLAS, Sept. 9, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, ...

Seeking Alpha - 6 months ago

SWK Holdings Corporation (SWKH) CEO Winston Black on Q2 2020 Results - Earnings Call Transcript

PRNewsWire - 6 months ago

DALLAS, Aug. 14, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, announced that the Company will host a conference call and live...

PRNewsWire - 8 months ago

DALLAS, June 23, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, announced today that Chairman and CEO Winston Black will presen...

About SWKH

SWK Holdings Corporation, a specialized finance company, focuses on the healthcare sector. The company operates through two segments, Finance Receivables and Pharmaceutical Development. It provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. The company, through its subsidiary, SWK Advisors LLC, offers non-discretionary investment advisory s... [Read more...]

Industry
Asset Management
IPO Date
Sep 22, 1999
CEO
Winston Lee Black III
Employees
32
Stock Exchange
NASDAQ
Ticker Symbol
SWKH
Full Company Profile

Financial Performance

In 2019, SWK Holdings's revenue was $30.75 million, an increase of 18.30% compared to the previous year's $25.99 million. Earnings were $23.83 million, an increase of 284.63%.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for SWK Holdings stock is "Buy." The 12-month stock price forecast is 23.00, which is an increase of 68.13% from the latest price.

Price Target
$23.00
(68.13% upside)
Analyst Consensus: Buy